These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23549268)

  • 1. Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.
    Janko C; Dürr S; Munoz LE; Lyer S; Chaurio R; Tietze R; Löhneysen Sv; Schorn C; Herrmann M; Alexiou C
    Int J Mol Sci; 2013 Apr; 14(4):7341-55. PubMed ID: 23549268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.
    Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C
    Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
    Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
    Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of Mitoxantrone-loaded Superparamagnetic Iron Oxide Nanoparticles in a HT-29 Tumour Spheroid Model.
    Hornung A; Poettler M; Friedrich RP; Weigel B; Duerr S; Zaloga J; Cicha I; Alexiou C; Janko C
    Anticancer Res; 2016 Jun; 36(6):3093-101. PubMed ID: 27272833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.
    Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S
    Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular effects of paclitaxel-loaded iron oxide nanoparticles on breast cancer using different 2D and 3D cell culture models.
    Lugert S; Unterweger H; Mühlberger M; Janko C; Draack S; Ludwig F; Eberbeck D; Alexiou C; Friedrich RP
    Int J Nanomedicine; 2019; 14():161-180. PubMed ID: 30613144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals.
    Alev M; Egenberger L; Mühleisen L; Weigel B; Frey B; Friedrich RP; Pöttler M; Alexiou C; Janko C
    J Control Release; 2018 Sep; 285():67-80. PubMed ID: 30008372
    [No Abstract]   [Full Text] [Related]  

  • 8. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
    Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
    J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the effect of SPION size in a stent assisted magnetic drug targeting system with interparticle interactions.
    Mardinoglu A; Cregg PJ
    ScientificWorldJournal; 2015; 2015():618658. PubMed ID: 25815370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient drug-delivery using magnetic nanoparticles--biodistribution and therapeutic effects in tumour bearing rabbits.
    Tietze R; Lyer S; Dürr S; Struffert T; Engelhorn T; Schwarz M; Eckert E; Göen T; Vasylyev S; Peukert W; Wiekhorst F; Trahms L; Dörfler A; Alexiou C
    Nanomedicine; 2013 Oct; 9(7):961-71. PubMed ID: 23669367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetite-dextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets - sarcoma treatment in progress.
    Krukemeyer MG; Krenn V; Jakobs M; Wagner W
    J Drug Target; 2012 Feb; 20(2):185-93. PubMed ID: 22044194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
    Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
    Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone- and Folate-TPGS2k Conjugate Hybrid Micellar Aggregates To Circumvent Toxicity and Enhance Efficiency for Breast Cancer Therapy.
    Guissi NE; Li H; Xu Y; Semcheddine F; Chen M; Su Z; Ping Q
    Mol Pharm; 2017 Apr; 14(4):1082-1094. PubMed ID: 28191959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake.
    Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP
    Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
    Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
    Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A superparamagnetic Fe3O4-loaded polymeric nanocarrier for targeted delivery of evodiamine with enhanced antitumor efficacy.
    Lv Y; Ding G; Zhai J; Guo Y; Nie G; Xu L
    Colloids Surf B Biointerfaces; 2013 Oct; 110():411-8. PubMed ID: 23759382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic Effect of 5-Fluorouracil-loaded Polymer-coated Magnetite Nanographene Oxide Combined with Radiofrequency.
    Asadi L; Shirvalilou S; Khoee S; Khoei S
    Anticancer Agents Med Chem; 2018; 18(8):1148-1155. PubMed ID: 29623854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionizing radiation improves glioma-specific targeting of superparamagnetic iron oxide nanoparticles conjugated with cmHsp70.1 monoclonal antibodies (SPION-cmHsp70.1).
    Shevtsov MA; Nikolaev BP; Ryzhov VA; Yakovleva LY; Marchenko YY; Parr MA; Rolich VI; Mikhrina AL; Dobrodumov AV; Pitkin E; Multhoff G
    Nanoscale; 2015 Dec; 7(48):20652-64. PubMed ID: 26599206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin prodrug conjugated Fe
    Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
    J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyethylenimine-coated superparamagnetic iron oxide nanoparticles impair in vitro and in vivo angiogenesis.
    Mulens-Arias V; Rojas JM; Sanz-Ortega L; Portilla Y; Pérez-Yagüe S; Barber DF
    Nanomedicine; 2019 Oct; 21():102063. PubMed ID: 31326525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.